Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · IEX Real-Time Price · USD
86.53
+0.55 (0.64%)
At close: Jul 26, 2024, 4:00 PM
88.43
+1.90 (2.20%)
After-hours: Jul 26, 2024, 6:30 PM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 545 employees as of February 13, 2024. The number of employees increased by 172 or 46.11% compared to the previous year.
Employees
545
Change (1Y)
172
Growth (1Y)
46.11%
Revenue / Employee
$460,593
Profits / Employee
-$543,811
Market Cap
4.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Feb 13, 2024 | 545 | 172 | 46.11% |
Feb 21, 2023 | 373 | 265 | 245.37% |
Feb 22, 2022 | 108 | 48 | 80.00% |
Feb 22, 2021 | 60 | 15 | 33.33% |
Mar 6, 2020 | 45 | 16 | 55.17% |
Mar 11, 2019 | 29 | 4 | 16.00% |
Mar 2, 2018 | 25 | 3 | 13.64% |
Mar 2, 2017 | 22 | 11 | 100.00% |
Mar 22, 2016 | 11 | 4 | 57.14% |
Oct 13, 2015 | 7 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Surgery Partners | 13,500 |
Integer Holdings | 10,500 |
Guardant Health | 1,779 |
Waystar Holding | 1,400 |
Ultragenyx Pharmaceutical | 1,276 |
Inspire Medical Systems | 1,011 |
Crinetics Pharmaceuticals | 290 |
Avidity Biosciences | 253 |
AXSM News
- 4 days ago - Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future - Benzinga
- 7 weeks ago - Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories - GlobeNewsWire
- 7 weeks ago - Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month - GlobeNewsWire
- 2 months ago - Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024 - GlobeNewsWire
- 2 months ago - Axsome Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Axsome Therapeutics Recognizes May as Mental Health Awareness Month - GlobeNewsWire
- 3 months ago - Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting - GlobeNewsWire